Oxygen Biotherapeutics Inc. (OXBO.OB) to Submit Test Protocol to FDA for Multi-Center Study for Traumatic Brain Injury
Oxygen Biotherapeutics Inc. (OTCBB: OXBO) engages in marketing innovative pharmaceuticals and medical devices to monitor respiration in patients suffering from…